Application no. and date | 09792207.4 (espacenet) (Federated) (European Patent Register), 20090903 | Patent/reg. no. and date | DK/EP 2323633, 20120321 | Publication date | 20110525 | Priority no. and date | US 94131 P, 20080904 | EP pub. no. and date |
EP 2323633 20110525 | Effective date | | Applicant/owner | VIIV Healthcare UK(No.4) Limited, 980 Great West Road Brentford, Middlesex TW8 9GS, GB | Applicant ref. no. | 160603 | Inventor | BROWN, Jonathan, R., c/o Bristol-Myers Squibb Company Reeds Lane Moreton
Merseyside CH46 1QW, GB, TOALE, Helen, c/o Bristol-Myers Squibb Company Reeds Lane Moreton
Merseyside CH46 1QW, GB, DENNIS, Andrew, B., c/o Bristol-Myers Squibb Company Reeds Lane Moreton
Merseyside CH46 1QW, GB, TIMMINS, Peter, c/o Bristol-Myers Squibb Company Reeds Lane Moreton
Merseyside CH46 1QW, GB | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 31/00 (2006.01) , A61K 9/20 (2006.01) | Title | Stabil, farmaceutisk sammensætning til optimeret indgivelse af en hiv-bindingshæmmer | Int. application no. | US2009055820 | Int. publication no. | WO2010028108 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|